referenCes
Abbasi, K. 2004. “Compulsory Registration of Clinical Trials.” Vol. 329:637–38.
London: bmj Publishing Group.
Abboud, L. 2004. “Should Family Doctors Treat Serious Mental Illness? Psychia-
trists Voice Concerns as More General Physicians Prescribe Antipsychotic Drugs.”
Wall Street Journal, March 24.
Abramson, J. 2004. Overdo$ed America: The Broken Promise of American Medicine.
New York: HarperCollins.
Agnvall, E. 2004. “Making Us (Nearly) Sick: A Majority of Americans Are Now Con-
sidered to Have at Least One ‘Pre- Disease’ or ‘Borderline’ Condition.” Washington
Post, February 10.
Aikin, K. J. 2002. Direct- to- Consumer Advertising of Prescription Drugs: Physician Sur-
vey Preliminary Results. Retrieved January 25, 2003, from http://www.fda.gov/cder/
ddmac/globalsummit2003/.
Akinbami L. J., X. Liu, P. N. Pastor, and C. A. Reuben. 2011. “Attention Deficit
Hyperactivity Disorder among Children Aged 5–17 Years in the United States,
1998–2009.” nchs Data Brief, no 70. Hyattsville, Md.: National Center for
Health Statistics. Retrieved March 15, 2012, from http://www.cdc.gov/nchs/data/
databriefs/db70.htm.
Aldes, J. L. 2008. “The fdA Clinical Trial Process: Effectuating Change in the Regu-
latory Framework Governing Clinical Trials to Account for the Historical Shift
from ‘Traditional’ to ‘New’ Phase I Trials.” Health Matrix 18 (2), 463–500.
Alexander, T. 1996. “Still Waiting, Watchfully: A Former Fortune Writer Whose
Unorthodox Choice in Facing Prostate Cancer Captivated Readers Reports on His
Progress.” cnn Money 133 (9), 73, May 13. Retrieved March 15, 2012, from http://
money.cnn.com/magazines/fortune/fortune_archive/1996/05/13/212400/index
.htm.
Allen, S., and S. Smith. 2004. “Statin Nation: Do We All Need to Lower Our ‘Bad’
Cholesterol?” Boston Globe, March 16, C1.
Previous Page Next Page